• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物共晶形成剂对介孔硅中药物共晶溶出的影响。

Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica.

机构信息

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang KM 21, Sumedang 45363, Indonesia.

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

出版信息

Int J Pharm. 2021 May 1;600:120492. doi: 10.1016/j.ijpharm.2021.120492. Epub 2021 Mar 17.

DOI:10.1016/j.ijpharm.2021.120492
PMID:33744448
Abstract

In this study, the molecular state of ritonavir (RTN)-saccharin (SAC) coamorphous incorporated into mesoporous silica by solvent evaporation and the effect of SAC on the RTN dissolution from mesopores were investigated. The amorphization of RTN-SAC was confirmed as a halo pattern in powder X-ray diffraction measurements and a single glass transition event in the modulated differential scanning calorimetry (MDSC) curve. C solid-state NMR spectroscopy revealed a hydrogen bond between the thiazole nitrogen of RTN and the amine proton of SAC. The glass transition of the RTN-SAC coamorphous in mesoporous silica was not found in the MDSC curve, indicating that RTN and SAC were monomolecularly incorporated into the mesopores. Solid-state NMR measurements suggested that the co-incorporation of SAC into the mesopores decreased the local mobility of the thiazole group of RTN via hydrogen bond formation. The RTN-SAC 1:1 coamorphous in mesoporous silica retained the X-ray halo-patterns after 30 d of storage, even under high temperature and humidity conditions. In the dissolution test, the RTN-SAC 1:1 coamorphous in mesoporous silica maintained RTN supersaturation for a longer time than the RTN amorphous in mesoporous silica. This study demonstrated that the drug-coformer interaction within mesoporous silica can significantly improve drug dissolution.

摘要

在这项研究中,通过溶剂蒸发法将利托那韦(RTN)-糖精(SAC)共无定形物掺入介孔硅中,并研究了 SAC 对 RTN 从介孔中溶解的影响。通过粉末 X 射线衍射测量证实了 RTN-SAC 的无定形化为晕环图案,在调制差示扫描量热法(MDSC)曲线上为单个玻璃化转变事件。固态 NMR 光谱表明 RTN 的噻唑氮和 SAC 的胺质子之间存在氢键。在 MDSC 曲线上未发现介孔硅中 RTN-SAC 共无定形的玻璃化转变,表明 RTN 和 SAC 以单分子形式掺入介孔中。固态 NMR 测量表明,SAC 共掺入介孔会通过氢键形成降低 RTN 的噻唑基团的局部迁移率。即使在高温高湿条件下,介孔硅中的 RTN-SAC 1:1 共无定形物在 30 天后仍保留 X 射线晕环图案。在溶解测试中,与介孔硅中的 RTN 无定形相比,介孔硅中的 RTN-SAC 1:1 共无定形物能更长时间维持 RTN 的过饱和状态。这项研究表明,药物共晶剂在介孔硅内的相互作用可显著提高药物的溶解速率。

相似文献

1
Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica.药物共晶形成剂对介孔硅中药物共晶溶出的影响。
Int J Pharm. 2021 May 1;600:120492. doi: 10.1016/j.ijpharm.2021.120492. Epub 2021 Mar 17.
2
Characterization of Drugs with Good Glass Formers in Loaded-Mesoporous Silica and Its Theoretical Value Relevance with Mesopores Surface and Pore-Filling Capacity.负载型介孔二氧化硅中具有良好玻璃形成剂的药物表征及其与介孔表面和孔填充能力的理论值相关性
Pharmaceuticals (Basel). 2022 Jan 13;15(1):93. doi: 10.3390/ph15010093.
3
Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.将伊布替尼制备成与糖精共无定形状态以提高其溶解度、溶出度和生物利用度。
J Pharm Sci. 2019 Sep;108(9):3020-3028. doi: 10.1016/j.xphs.2019.04.031. Epub 2019 May 5.
4
Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.介孔硅纳米限域下吡喹酮药物共晶的形成:固体形态对溶出增强的影响。
Mol Pharm. 2022 Feb 7;19(2):414-431. doi: 10.1021/acs.molpharmaceut.1c00606. Epub 2021 Dec 30.
5
Coamorphous repaglinide-saccharin with enhanced dissolution.具有增强溶解性能的考阿摩尔型瑞格列奈-糖精共无定形物。
Int J Pharm. 2013 Jun 25;450(1-2):290-5. doi: 10.1016/j.ijpharm.2013.04.032. Epub 2013 Apr 21.
6
Drug-Coformer Loaded-Mesoporous Silica Nanoparticles: A Review of the Preparation, Characterization, and Mechanism of Drug Release.载药共晶介孔硅纳米粒子:药物释放的制备、表征和机制研究综述。
Int J Nanomedicine. 2024 Jan 12;19:281-305. doi: 10.2147/IJN.S449159. eCollection 2024.
7
The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State.纳米受限下布洛芬-烟酰胺二元体系:从共晶到无定形态。
J Pharm Sci. 2017 Oct;106(10):3150-3155. doi: 10.1016/j.xphs.2017.06.005. Epub 2017 Jun 15.
8
Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.将络合作用纳入共无定形系统可显著提高无定形盐酸鲁拉西酮的溶解性能并消除其胶凝作用。
Mol Pharm. 2020 Jan 6;17(1):84-97. doi: 10.1021/acs.molpharmaceut.9b00772. Epub 2019 Dec 16.
9
A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.载有无定形药物的介孔二氧化硅与通过溶剂蒸发制备的纯无定形药物之间药学性质的比较研究。
Pharmaceuticals (Basel). 2022 Jun 9;15(6):730. doi: 10.3390/ph15060730.
10
Mechanistic insights into the crystallization of coamorphous drug systems.探讨共无定形药物系统结晶的机制见解。
J Control Release. 2023 Feb;354:489-502. doi: 10.1016/j.jconrel.2023.01.019. Epub 2023 Jan 19.

引用本文的文献

1
Long-Term Stabilized and Highly Soluble Bezafibrate-Gliclazide Co-Amorphous Binary System.长效稳定且高溶解性的苯扎贝特-格列齐特共无定形二元体系。
AAPS PharmSciTech. 2025 Jan 30;26(1):48. doi: 10.1208/s12249-025-03045-3.
2
Characterization of Alpha Mangostin Loaded-Mesoporous Silica Nanoparticle and the Impact on Dissolution and Physical Stability.负载α-山竹黄酮的介孔二氧化硅纳米颗粒的表征及其对溶解和物理稳定性的影响。
Nanotechnol Sci Appl. 2025 Jan 9;18:1-13. doi: 10.2147/NSA.S499007. eCollection 2025.
3
Drug-Coformer Loaded-Mesoporous Silica Nanoparticles: A Review of the Preparation, Characterization, and Mechanism of Drug Release.
载药共晶介孔硅纳米粒子:药物释放的制备、表征和机制研究综述。
Int J Nanomedicine. 2024 Jan 12;19:281-305. doi: 10.2147/IJN.S449159. eCollection 2024.
4
Effect of Drug-Polymer Interaction in Amorphous Solid Dispersion on the Physical Stability and Dissolution of Drugs: The Case of Alpha-Mangostin.药物 - 聚合物相互作用对无定形固体分散体中药物物理稳定性和溶出度的影响:以α-山竹黄酮为例
Polymers (Basel). 2023 Jul 13;15(14):3034. doi: 10.3390/polym15143034.
5
Mesoporous Drug Delivery System: From Physical Properties of Drug in Solid State to Controlled Release.介孔药物输送系统:从药物的固态物理性质到控制释放。
Molecules. 2023 Apr 12;28(8):3406. doi: 10.3390/molecules28083406.
6
Characterizing the Impact of Chitosan on the Nucleation and Crystal Growth of Ritonavir from Supersaturated Solutions.表征壳聚糖对利托那韦从过饱和溶液中形核和晶体生长的影响。
Polymers (Basel). 2023 Mar 3;15(5):1282. doi: 10.3390/polym15051282.
7
Supersaturation and Precipitation Applicated in Drug Delivery Systems: Development Strategies and Evaluation Approaches.超饱和度和沉淀在药物传递系统中的应用:开发策略和评价方法。
Molecules. 2023 Feb 27;28(5):2212. doi: 10.3390/molecules28052212.
8
Current Techniques of Water Solubility Improvement for Antioxidant Compounds and Their Correlation with Its Activity: Molecular Pharmaceutics.抗氧化化合物水溶性改善的当前技术及其与活性的相关性:分子药剂学
Antioxidants (Basel). 2023 Feb 4;12(2):378. doi: 10.3390/antiox12020378.
9
Inhibition of Crystal Nucleation and Growth in Aqueous Drug Solutions: Impact of Different Polymers on the Supersaturation Profiles of Amorphous Drugs-The Case of Alpha-Mangostin.抑制药物水溶液中的晶体成核与生长:不同聚合物对无定形药物过饱和曲线的影响——以α-山竹素为例
Pharmaceutics. 2022 Nov 5;14(11):2386. doi: 10.3390/pharmaceutics14112386.
10
Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.共无定形药物递送系统:物理稳定性、体外和体内性能的综述。
AAPS PharmSciTech. 2022 Sep 19;23(7):259. doi: 10.1208/s12249-022-02421-7.